Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

MYBL2 Is a Candidate Tumor Suppressor Gene In MDS

Stefan Heinrichs, Lily Conover, Carlos E. Bueso-Ramos, Outi Kilpivaara, Ross Levine, MD, Kristen Stevenson, Donna Neuberg, ScD, Rafael Bejar, MD, PhD, Benjamin L. Ebert, MD, DPhil, Guillermo Garcia-Manero, MD, Hagop M. Kantarjian, MD, A. Thomas Look, MD

Blood (2010) 116 (21): 1865.

https://doi.org/10.1182/blood.V116.21.1865.1865

Published: 2010

Journal Articles

High Mitochondrial Membrane Potential Identifies Patients with Myeloproliferative Neoplasms with a More Aggressive Natural History

Jeffrey R Gardner, MBA, Omar Abdel-Wahab, Mark Frattini, MD, Joseph G Jurcic, MD, Kristina Knapp, Todd L. Rosenblat, MD, MS, Gerald A. Soff, MD, Ross Levine, MD, Mark Heaney, MD, PhD

Blood (2010) 116 (21): 1992.

https://doi.org/10.1182/blood.V116.21.1992.1992

Published: 2010

Journal Articles

Mir-9 Is Aberrantly Expressed In MPN Patients and Accelerates Erythropoietic Cell Growth and Differentiation

Xiaoqing Lin, Kim Rice, PhD, Martin Carroll, MD, Fabricio Costa, PhD, Outi Kilpivaara, Marcelo B. Soares, PhD, Ross Levine, MD, Jonathan D. Licht, MD

Blood (2010) 116 (21): 1983.

https://doi.org/10.1182/blood.V116.21.1983.1983

Published: 2010

Journal Articles

High Rates of Molecular Response After Long-Term Follow-up of Patients with Advanced Essential Thrombocythemia (ET) or Polycythemia Vera (PV) Treated with Pegylated Interferon-ALFA-2A (PEG-IFN-α-2A; PEGASYS)

Alfonso Quintás-Cardama, MD, Ross Levine, MD, Taghi Manshouri, Outi Kilpivaara, Hagop M. Kantarjian, MD, Srdan Verstovsek, MD, PhD

Blood (2010) 116 (21): 461.

https://doi.org/10.1182/blood.V116.21.461.461

Published: 2010

Journal Articles

High-Throughput Mutational Profiling In AML: Mutational Analysis of the ECOG E1900 Trial

Blood (2010) 116 (21): 851.

https://doi.org/10.1182/blood.V116.21.851.851

Published: 2010

Journal Articles

Concomitant Analysis of EZH2 and ASXL1 Mutations In Myelofibrosis, Chronic Myelomonocytic Leukemia and Blast-Phase Myeloproliferative Neoplasms

Omar Abdel-Wahab, Animesh Pardanani, MBBS, PhD, Jay Patel, Terra Lasho, MT, (ASCP), Adriana Heguy, Ross Levine, MD, Ayalew Tefferi, MD

Blood (2010) 116 (21): 3070.

https://doi.org/10.1182/blood.V116.21.3070.3070

Published: 2010

Journal Articles

Point Mutations In Myelodysplastic Syndromes Are Associated with Clinical Features and Are Independent Predictors of Overall Survival

Rafael Bejar, MD, PhD, Kristen Stevenson, Omar Abdel-Wahab, MD, McConkey Marie, PhD, Katherine Lin, James Randall McAuley, Kevin Cheung, MD, Naomi Galili, Ph.D., Guillermo Garcia-Manero, MD, Hagop Kantarjian, MD, Azra Raza, MD, Ross Levine, MD, Donna Neuberg, ScD, Benjamin L. Ebert, MD, DPhil

Blood (2010) 116 (21): 300.

https://doi.org/10.1182/blood.V116.21.300.300

Published: 2010

Journal Articles

Systematic Genomic Screen for Tyrosine Kinase Mutations in CLL.

Jennifer R. Brown, MD, PhD, Ross Levine, MD, Elke Raderschall, PhD, Christina Thompson, BS, D. Gary Gilliland, MD, Arnold S. Freedman, MD

Blood (2007) 110 (11): 2069.

https://doi.org/10.1182/blood.V110.11.2069.2069

Published: 2007

Journal Articles

The JAK2 Kinase Inhibitor LS104 Induces Growth-Arrest and Apoptosis in JAK2V617F Positive Cells.

Daniel B. Lipka, MD, Linda S. Hoffmann, MSc, Florian Heidel, MD, Boyka Markova, PhD, Stefan Kasper, MD, Frank Breitenbuecher, PhD, Thomas Kindler, MD, Ross Levine, MD, Joseph Elliot, PhD, Christoph Huber, MD, Thomas Fischer, MD

Blood (2007) 110 (11): 3544.

https://doi.org/10.1182/blood.V110.11.3544.3544

Published: 2007

Journal Articles

Large Regions of Uniparental Disomy (UPD) Establish Clonal Hematopoietic Stem Cell Selection in a Subset of Myelodysplastic Syndrome (MDS) Patients with Normal Bone Marrow Cell Karyotypes.

Stefan Heinrichs, PhD, Rima V. Kulkarni, Carlos E. Bueso-Ramos, MD, Mignon Loh, MD, Ross Levine, MD, Cheng Li, Donna S. Neuberg, Steve M. Kornblau, MD, Jean-Pierre Issa, MD, D. Gary Gilliland, MD, Elihu H. Estey, MD, A. Thomas Look, MD

Blood (2007) 110 (11): 120.

https://doi.org/10.1182/blood.V110.11.120.120

Published: 2007

Journal Articles

MPL W515L/K and JAK2 V617F Mutations: Single Colony Studies, Lineage Restriction, and Chronology of Clonal Emergence.

Animesh Pardanani, MD, PhD, Terra Lasho, Christy Finke, Ruben Mesa, MD, William Hogan, MD, Ross Levine, MD, D. Gary Gilliland, MD, PhD, Ayalew Tefferi, MD

Blood (2006) 108 (11): 116.

https://doi.org/10.1182/blood.V108.11.116.116

Published: 2006

Journal Articles

High Resolution SNP Arrays and Correlation with Expression Arrays Identify Novel Genomic Aberrations and Potential Disease Genes in Polycythemia Vera and Other Myeloproliferative Disorders.

Weijia Zhang, PhD, Windy Berkofsky-Fessler, MPhil, Ross Levine, MD, Yezhou Sun, MS, D. Gary Gilliland, MD, Jonathan D. Licht, MD

Blood (2006) 108 (11): 359.

https://doi.org/10.1182/blood.V108.11.359.359

Published: 2006

Journal Articles

Creating a National Cohort of Myeloproliferative Disorders Using the Internet: A Feasibility Study.

Martha Wadleigh, MD, Tarrah Kirkpatrick, Arnold Gonzales, Ross Levine, MD, D. G. Gilliland, MD, PhD, Stephanie J. Lee, MD, MPH

Blood (2004) 104 (11): 270.

https://doi.org/10.1182/blood.V104.11.270.270

Published: 2004

NARROW

MYBL2 Is a Candidate Tumor Suppressor Gene In MDS

High Mitochondrial Membrane Potential Identifies Patients with Myeloproliferative Neoplasms with a More Aggressive Natural History

Mir-9 Is Aberrantly Expressed In MPN Patients and Accelerates Erythropoietic Cell Growth and Differentiation

High Rates of Molecular Response After Long-Term Follow-up of Patients with Advanced Essential Thrombocythemia (ET) or Polycythemia Vera (PV) Treated with Pegylated Interferon-ALFA-2A (PEG-IFN-α-2A; PEGASYS)

High-Throughput Mutational Profiling In AML: Mutational Analysis of the ECOG E1900 Trial

Concomitant Analysis of EZH2 and ASXL1 Mutations In Myelofibrosis, Chronic Myelomonocytic Leukemia and Blast-Phase Myeloproliferative Neoplasms

Point Mutations In Myelodysplastic Syndromes Are Associated with Clinical Features and Are Independent Predictors of Overall Survival

Systematic Genomic Screen for Tyrosine Kinase Mutations in CLL.

The JAK2 Kinase Inhibitor LS104 Induces Growth-Arrest and Apoptosis in JAK2V617F Positive Cells.

Large Regions of Uniparental Disomy (UPD) Establish Clonal Hematopoietic Stem Cell Selection in a Subset of Myelodysplastic Syndrome (MDS) Patients with Normal Bone Marrow Cell Karyotypes.

MPL W515L/K and JAK2 V617F Mutations: Single Colony Studies, Lineage Restriction, and Chronology of Clonal Emergence.

High Resolution SNP Arrays and Correlation with Expression Arrays Identify Novel Genomic Aberrations and Potential Disease Genes in Polycythemia Vera and Other Myeloproliferative Disorders.

Creating a National Cohort of Myeloproliferative Disorders Using the Internet: A Feasibility Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only